Vision & mission
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals, is a North American biopharmaceutical company that was established in 2015 in Cambridge, Massachusetts and recently expanded into Canada.
At Akcea, we envision a future in which patients with rare diseases can lead full and happy lives despite the inherent challenges of their conditions. Our mission is to provide these patients with educational resources, innovative products and ongoing support in order to help them realize this dream.
The leadership team at Akcea brings unmatched collective experience that is critical in guiding the company’s effort to develop therapies that focus on serious and rare diseases. The team values a strong partnering philosophy with physicians, patients, regulators and others in the industry to help advance treatment options for people living with these conditions.
“At Akcea, we take our obligations to patients, caregivers and healthcare professionals seriously ‒ whether it’s designing and delivering clinical programs, engaging communities or working tirelessly to make our innovative and transformative treatments available to Canadians living with serious and rare diseases. We are committed to truly listening to those we serve and offering enhanced support to patients, their families and those who care for them.
While we are a company new to Canada, we are a team with a wealth of experience working in the unique area of rare disease here at home and around the world. We understand the unique challenges facing the Canadian healthcare system, as well our responsibility to ethically and passionately partner with healthcare professionals and support communities in making a unique and positive impact on the lives of patients and their families.”
Vice President & GM Canada
Interested in joining our dynamic team? See our latest job openings.